These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32910904)

  • 21. HMGB1 binds to the rs7903146 locus in TCF7L2 in human pancreatic islets.
    Zhou Y; Oskolkov N; Shcherbina L; Ratti J; Kock KH; Su J; Martin B; Oskolkova MZ; Göransson O; Bacon J; Li W; Bucciarelli S; Cilio C; Brazma A; Thatcher B; Rung J; Wierup N; Renström E; Groop L; Hansson O
    Mol Cell Endocrinol; 2016 Jul; 430():138-45. PubMed ID: 26845344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcription factor 7-like 2 (TCF7L2) regulates activin receptor-like kinase 1 (ALK1)/Smad1 pathway for development of diabetic nephropathy.
    Araoka T; Abe H; Tominaga T; Mima A; Matsubara T; Murakami T; Kishi S; Nagai K; Doi T
    Mol Cells; 2010 Sep; 30(3):209-18. PubMed ID: 20803090
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Zhang X; Ye P; Huang H; Wang B; Dong F; Ling Q
    Aging (Albany NY); 2020 Jul; 12(13):13365-13387. PubMed ID: 32651957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcription Factor 7-like 2 Mediates Canonical Wnt/β-Catenin Signaling and c-Myc Upregulation in Heart Failure.
    Hou N; Ye B; Li X; Margulies KB; Xu H; Wang X; Li F
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coordinated
    Chater-Diehl E; Sokolowski D; Alberry B; Singh SM
    Biochem Cell Biol; 2019 Aug; 97(4):375-379. PubMed ID: 30398926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute Wnt pathway activation positively regulates leptin gene expression in mature adipocytes.
    Chen ZL; Shao WJ; Xu F; Liu L; Lin BS; Wei XH; Song ZL; Lu HG; Fantus IG; Weng JP; Jin TR
    Cell Signal; 2015 Mar; 27(3):587-97. PubMed ID: 25550093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion.
    Bass AJ; Lawrence MS; Brace LE; Ramos AH; Drier Y; Cibulskis K; Sougnez C; Voet D; Saksena G; Sivachenko A; Jing R; Parkin M; Pugh T; Verhaak RG; Stransky N; Boutin AT; Barretina J; Solit DB; Vakiani E; Shao W; Mishina Y; Warmuth M; Jimenez J; Chiang DY; Signoretti S; Kaelin WG; Spardy N; Hahn WC; Hoshida Y; Ogino S; DePinho RA; Chin L; Garraway LA; Fuchs CS; Baselga J; Tabernero J; Gabriel S; Lander ES; Getz G; Meyerson M
    Nat Genet; 2011 Sep; 43(10):964-968. PubMed ID: 21892161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide identification of TCF7L2/TCF4 target miRNAs reveals a role for miR-21 in Wnt-driven epithelial cancer.
    Lan F; Yue X; Han L; Shi Z; Yang Y; Pu P; Yao Z; Kang C
    Int J Oncol; 2012 Feb; 40(2):519-26. PubMed ID: 21956205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An alternative polyadenylation signal in TCF7L2 generates isoforms that inhibit T cell factor/lymphoid-enhancer factor (TCF/LEF)-dependent target genes.
    Locke JM; Da Silva Xavier G; Rutter GA; Harries LW
    Diabetologia; 2011 Dec; 54(12):3078-82. PubMed ID: 21913056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The transcription factor 7 like 2‑binding protein TIP5 activates β‑catenin/transcription factor signaling in hepatocellular carcinoma.
    Li C; Wu W; Ding H; Li Q; Xie K
    Mol Med Rep; 2018 Jun; 17(6):7645-7651. PubMed ID: 29620186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The type 2 diabetes presumed causal variant within TCF7L2 resides in an element that controls the expression of ACSL5.
    Xia Q; Chesi A; Manduchi E; Johnston BT; Lu S; Leonard ME; Parlin UW; Rappaport EF; Huang P; Wells AD; Blobel GA; Johnson ME; Grant SFA
    Diabetologia; 2016 Nov; 59(11):2360-2368. PubMed ID: 27539148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells.
    Hatzis P; van der Flier LG; van Driel MA; Guryev V; Nielsen F; Denissov S; Nijman IJ; Koster J; Santo EE; Welboren W; Versteeg R; Cuppen E; van de Wetering M; Clevers H; Stunnenberg HG
    Mol Cell Biol; 2008 Apr; 28(8):2732-44. PubMed ID: 18268006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcription factor-associated combinatorial epigenetic pattern reveals higher transcriptional activity of TCF7L2-regulated intragenic enhancers.
    Liu Q; Bonneville R; Li T; Jin VX
    BMC Genomics; 2017 May; 18(1):375. PubMed ID: 28499350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statistics of protein-DNA binding and the total number of binding sites for a transcription factor in the mammalian genome.
    Kuznetsov VA; Singh O; Jenjaroenpun P
    BMC Genomics; 2010 Feb; 11 Suppl 1(Suppl 1):S12. PubMed ID: 20158869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m
    Liu H; Li D; Sun L; Qin H; Fan A; Meng L; Graves-Deal R; Glass SE; Franklin JL; Liu Q; Wang J; Yeatman TJ; Guo H; Zong H; Jin S; Chen Z; Deng T; Fang Y; Li C; Karijolich J; Patton JG; Wang X; Nie Y; Fan D; Coffey RJ; Zhao X; Lu Y
    Mol Cancer; 2022 Mar; 21(1):74. PubMed ID: 35279145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TCF7L2 modulates glucose homeostasis by regulating CREB- and FoxO1-dependent transcriptional pathway in the liver.
    Oh KJ; Park J; Kim SS; Oh H; Choi CS; Koo SH
    PLoS Genet; 2012 Sep; 8(9):e1002986. PubMed ID: 23028378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass.
    Takamoto I; Kubota N; Nakaya K; Kumagai K; Hashimoto S; Kubota T; Inoue M; Kajiwara E; Katsuyama H; Obata A; Sakurai Y; Iwamoto M; Kitamura T; Ueki K; Kadowaki T
    Diabetologia; 2014 Mar; 57(3):542-53. PubMed ID: 24317852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanistic basis and efficacy of targeting the β-catenin-TCF7L2-JMJD6-c-Myc axis to overcome resistance to BET inhibitors.
    Saenz DT; Fiskus W; Mill CP; Perera D; Manshouri T; Lara BH; Karkhanis V; Sharma S; Horrigan SK; Bose P; Kadia TM; Masarova L; DiNardo CD; Borthakur G; Khoury JD; Takahashi K; Bhaskara S; Lin CY; Green MR; Coarfa C; Crews CM; Verstovsek S; Bhalla KN
    Blood; 2020 Apr; 135(15):1255-1269. PubMed ID: 32068780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atheroprotective Flow Upregulates ITPR3 (Inositol 1,4,5-Trisphosphate Receptor 3) in Vascular Endothelium via KLF4 (Krüppel-Like Factor 4)-Mediated Histone Modifications.
    He M; Huang TS; Li S; Hong HC; Chen Z; Martin M; Zhou X; Huang HY; Su SH; Zhang J; Wang WT; Kang J; Huang HD; Zhang J; Chien S; Shyy JY
    Arterioscler Thromb Vasc Biol; 2019 May; 39(5):902-914. PubMed ID: 30917677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted deletion of Tcf7l2 in adipocytes promotes adipocyte hypertrophy and impaired glucose metabolism.
    Geoghegan G; Simcox J; Seldin MM; Parnell TJ; Stubben C; Just S; Begaye L; Lusis AJ; Villanueva CJ
    Mol Metab; 2019 Jun; 24():44-63. PubMed ID: 30948248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.